Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals.
Autor: | Miljković N; Institute for Orthopaedic Surgery 'Banjica', University of Belgrade, Belgrade, Serbia., Godman B; Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.; Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde University, Glasgow, United Kingdom.; Department of Public Health and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa., van Overbeeke E; Clinical Pharmacology and Pharmacotherapy, KU Leuven, Leuven, Belgium., Kovačević M; Department of Pharmacokinetics and Clinical Pharmacy, University of Belgrade, Belgrade, Serbia., Tsiakitzis K; General Hospital of Thessaloniki 'G. Papanikolaou', Hospital Pharmacy Department, Thessaloniki, Greece., Apatsidou A; General Hospital of Thessaloniki 'G. Papanikolaou', Hospital Pharmacy Department, Thessaloniki, Greece., Nikopoulou A; General Hospital of Thessaloniki 'G. Papanikolaou', Hospital Pharmacy Department, Thessaloniki, Greece., Yubero CG; Hospital Pharmacy Department, University Hospital 'Infanta Sofia', Madrid, Spain., Portillo Horcajada L; Hospital Pharmacy Department, University Hospital 'Infanta Sofia', Madrid, Spain., Stemer G; Gunar Stemer, Medicines Information and Clinical Pharmacy Services, Vienna General Hospital, Vienna, Austria., Kuruc-Poje D; General Hospital 'Dr. Tomislav Bardek', Hospital Pharmacy Department, Koprivnica, Croatia., De Rijdt T; Pharmacy Department, University Hospitals Leuven, UZ Herestraat, Leuven, Belgium., Bochenek T; Department of Drug Management, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland., Huys I; Clinical Pharmacology and Pharmacotherapy, KU Leuven, Leuven, Belgium., Miljković B; Department of Pharmacokinetics and Clinical Pharmacy, University of Belgrade, Belgrade, Serbia. |
---|---|
Jazyk: | angličtina |
Zdroj: | Frontiers in medicine [Front Med (Lausanne)] 2020 May 12; Vol. 7, pp. 157. Date of Electronic Publication: 2020 May 12 (Print Publication: 2020). |
DOI: | 10.3389/fmed.2020.00157 |
Abstrakt: | Introduction: Medicine shortages result in great risk for the continuity of patient care especially for antimicrobial treatment, potentially enhancing resistance rates and having a higher economic impact. This study aims to identify, describe, assess, and assign risk priority levels to potential failures following substitution of antimicrobial treatment due to shortages among European hospitals. Furthermore, the study investigated the impact of corrective actions on risk reduction so as to provide guidance and improve future patient care. Methods: Health-care failure mode and effect analysis (HFMEA) was applied to hospitals in Austria (H-AT), Belgium (H-BE), Croatia (H-CR), Greece (H-GR), Spain (H-SP), and Serbia (H-SR). Multidisciplinary teams identified processes, failure modes, causes, and corrective actions related to antibiotic substitution following medicine shortages. Characteristics of study hospitals as well as severity, probability, and hazard scores (HSs) of failure modes/causes were analyzed using Microsoft Office Excel 2010 and IBM SPSS Statistics® via descriptive and inferential statistics. Results: Through HFMEA, 74 failure modes were identified, with 53 of these scoring 8 or above on the basis of assigned severity and probability for a failure. Severity of failure modes differed before and after corrective actions in H-CR, H-GR, and H-SR ( p < 0.005). Their probability differed in all study hospitals ( p < 0.005) when compared before and after corrective actions aimed to be implemented. The highest number of failure-mode causes was detected in H-CR (46) and the lowest in H-SP (16). Corrective actions can address failure modes and lower HSs; therein, all teams proposed the following: structuring communication among stakeholders, introducing electronic prescribing, strengthening pharmacists' involvement, and increasing effectiveness of the ward stock assessment. These proposed actions led to HS reductions up to 83%. Conclusion: There is a lack of structure in addressing risks associated with antibiotic substitution following shortages. Furthermore, lack of communication, data scarcity on availability of antibiotics, non-supportive information technology (IT) systems, and lack of internal substitution protocols hinder quick assessment of alternatives addressing patient needs. Nevertheless, the study shows that health-care professionals manage to secure optimal antimicrobial treatment for patients using available IT and human resources. (Copyright © 2020 Miljković, Godman, van Overbeeke, Kovačević, Tsiakitzis, Apatsidou, Nikopoulou, Yubero, Portillo Horcajada, Stemer, Kuruc-Poje, De Rijdt, Bochenek, Huys and Miljković.) |
Databáze: | MEDLINE |
Externí odkaz: |